The International Working Group discussed diagnosing Alzheimer's disease among cognitively unimpaired individuals in a ...

Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...

(Reuters) -Cassava Sciences on Monday said its experimental Alzheimer's disease drug did not meet the main or secondary goals ...

Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by ...

Stay alert with list of early signs and symptoms of dementia that disrupts daily life and may be a symptom of Alzheimer’s or ...

Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.

LAS VEGAS (KTNV) — November is National Alzheimer’s Awareness Month, and this year, experts are shining a light on a growing ...

Subtle signs of Alzheimer's disease can emerge decades before a diagnosis—often in the form of irregular behaviors that ...

A University of Liverpool study links Alzheimer’s disease to disrupted mechanical signaling between proteins APP and talin in ...